3DMEDiTech is an Australian-Israeli company which develops and delivers mass-customised medical devices utilising 3D printing.
3DMorphic is an Australian orthopaedic devices company offering rapidly personalised, 3D printed surgical devices that improve clinical outcomes and contain costs.
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories.
AbilityMate is a technology company engaged in the customisation and digital manufacture of custom-made medical devices. AbilityMate’s products help clinicians achieve the clinical results they expect and deliver effective, cutting-edge options and better experiences to their patients.
Accelagen is a full-service CRO focused on clinical trial development and regulatory affairs for the Biopharmaceutical and Medical Device industry.
Adarsh Australia is a leading manufacturer of custom medical, metal and plastic components in Perth, Western Australia.
Aim Lab is an award winning product design, engineering and manufacturing company base in Brisbane.
Allens is an international commercial law firm with offices throughout Australia and Asia. Allens are committed to providing excellent service remains the same: combining technical excellence with commercial insight to provide the clearest of answers.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
Analytica is the manufacturer of PeriCoach®, an e-health solution for Stress Urinary Incontinence, affecting millions of women globally. PeriCoach includes a device, an app to guide proper performance of pelvic muscle exercises, and a portal connection for patient management by a clinician.
Anatomics is a Melbourne-based and Australian-owned medical device company that has been manufacturing and marketing surgical products to surgeons locally and internationally since 1996.
ANDHealth is a national digital health initiative established by a consortium of commercial and government partners to facilitate and support the development & commercialisation of clinically validated digital health technologies across Australia.
Apollo is a clinically-driven medical imaging software company specializing in the creation of advanced software for healthcare applications including medical image processing and clinical data management. Since its incorporation in 2001, Apollo has been developing innovative software including advanced functional imaging applications and cost-effective cross-modality vertical solutions with automated workflow.
The ARC Training Centre in Biodevices aims to develop the next generation of industry-ready researchers and leaders in the medical device industry. They work in collaboration with various industry partners, focusing on identifying and implementing best practices for global competitiveness in MedTech product innovation, including opportunity identification, product design and development, quality systems, manufacturing processes, firm organisation and management.
ARCS Australia is a professional development association for people working in the development of therapeutic goods. Founded in 1984, ARCS serves all personnel committed to therapeutics development in Australia.
Artesian Invest is a multi-strategy investment manager focusing Venture Capital & Fixed Interest Investments. Their VC strategy is to invest in high growth potential startups that can build and exit their business on relatively low lifetime capital.
As Australia’s National Centre for Asia Capability, Asialink Business provides tailored solutions to help businesses seize the potential of diverse Asian markets.
The Association of Australian Medical Research Institutes (AAMRI) is the peak body for medical research institutes (MRIs) across Australia.
Atlantis Healthcare develops and delivers programs to support individual self-engagement and self-management of health.
AusBiotech is Australia’s biotechnology organisation, working on behalf of members for 30 years to provide representation and services to promote the global growth of Australian biotechnology.